Clinical Trial Update: Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral omadacycline to oral linezolid for acute bacterial skin and skin structure infections has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Infections
• Skin and Soft Tissue Infections

Drugs mentioned

• Linezolid (Linezolid)
• Omadacycline (omadacycline)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Bacterial Infections, Skin Structures and Soft Tissue Infections | Phase 3 | Status: COMPLETED | Results posted: 2018-11-30